Search research articles
Contact Us
Filters
Showing results (561-570 of 682) with videos related to
Page
of 69
Sort By:
Blood Advances
|
April 21, 2020
Measurement of ex vivo resistance to proteasome inhibitors, IMiDs, and daratumumab during multiple myeloma progression
Zachary J Walker, Michael J VanWyngarden, Brett M Stevens, et al.
Blood
|
January 30, 2008
The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
Saman Hewamana, Suhair Alghazal, Thet Thet Lin, et al.
Diabetes Care
|
March 2, 2022
Erratum. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532
Justin M Gregory, James C Slaughter, Sara H Duffus, et al.
Journal of Epidemiology and Global Health
|
July 17, 2013
Putting surveillance data into context: the role of health care utilization surveys in understanding population burden of pneumonia in developing countries
Meredith Deutscher, Chris Van Beneden, Deron Burton, et al.
Diabetes Care
|
December 3, 2020
COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes
Justin M Gregory, James C Slaughter, Sara H Duffus, et al.
Diabetes Care
|
May 11, 2021
Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532
Justin M Gregory, James C Slaughter, Sara H Duffus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 16, 2010
NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science
Mitchell S Cairo, Craig T Jordan, Carlo C Maley, et al.
Molecular Cancer Therapeutics
|
June 18, 2014
Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia
Monica L Guzman, Neng Yang, Krishan K Sharma, et al.
Neurology
|
April 26, 2020
Attracting neurology's next generation: A qualitative study of specialty choice and perceptions
Justin T Jordan, Carolyn Cahill, Tasha Ostendorf, et al.
Journal of Leukocyte Biology
|
November 6, 2020
MDS-associated SF3B1 mutations enhance proinflammatory gene expression in patient blast cells
Daniel A Pollyea, Hyun Min Kim, Brett M Stevens, et al.
Page
of 69
Search research articles
Search
Showing results (561-570 of 682) with videos related to
Sort By:
Page
of 69
Blood Advances
|
April 21, 2020
Measurement of ex vivo resistance to proteasome inhibitors, IMiDs, and daratumumab during multiple myeloma progression
Zachary J Walker, Michael J VanWyngarden, Brett M Stevens, et al.
Blood
|
January 30, 2008
The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
Saman Hewamana, Suhair Alghazal, Thet Thet Lin, et al.
Diabetes Care
|
March 2, 2022
Erratum. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532
Justin M Gregory, James C Slaughter, Sara H Duffus, et al.
Journal of Epidemiology and Global Health
|
July 17, 2013
Putting surveillance data into context: the role of health care utilization surveys in understanding population burden of pneumonia in developing countries
Meredith Deutscher, Chris Van Beneden, Deron Burton, et al.
Diabetes Care
|
December 3, 2020
COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes
Justin M Gregory, James C Slaughter, Sara H Duffus, et al.
Diabetes Care
|
May 11, 2021
Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532
Justin M Gregory, James C Slaughter, Sara H Duffus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 16, 2010
NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science
Mitchell S Cairo, Craig T Jordan, Carlo C Maley, et al.
Molecular Cancer Therapeutics
|
June 18, 2014
Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia
Monica L Guzman, Neng Yang, Krishan K Sharma, et al.
Neurology
|
April 26, 2020
Attracting neurology's next generation: A qualitative study of specialty choice and perceptions
Justin T Jordan, Carolyn Cahill, Tasha Ostendorf, et al.
Journal of Leukocyte Biology
|
November 6, 2020
MDS-associated SF3B1 mutations enhance proinflammatory gene expression in patient blast cells
Daniel A Pollyea, Hyun Min Kim, Brett M Stevens, et al.
Page
of 69